Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Become a Member | Sign in
Home>News>This Article

2013-15 Alfa Aesar Catalog Includes Over 8,000 New Products

Published: Tuesday, April 02, 2013
Last Updated: Tuesday, April 02, 2013
Bookmark and Share
Alfa Aesar, A Johnson Matthey Company, announces the publication of the 2013-15 Catalog of Research Chemicals, Metals & Materials.

The new catalog features over 8,000 new products, including new benzenesulfonamides, benzamides, homogeneous precious metal catalysts, chiral ligands, thioureas, heterocyclic compounds, click chemistry reagents, sulfonyl chlorides, carboxylic acids, boronic acids, fluorinated organics, Grignard reagents and many more. Many of the new products are unique and exclusive to Alfa Aesar.

Alfa Aesar continues to extensively augment the technical content of the catalog with thousands of new and updated application notes, synonym listings and other specification details. Molecular structure diagrams are included for most chemicals, and the catalog is extensively indexed by Chemical Abstract Service (CAS) number, stock number and molecular formula. The product listings for all hazardous substances are also enhanced with hazard pictograms and newly implemented precautionary and hazard phrases in accordance with Globally Harmonized System (GHS) standards.

In addition to chemical compounds, the catalog includes special sections listing pure elements and alloys. A full range of literature can be requested at, including catalogs listing analytical products, precious metal compounds and catalysts, and labware. All of Alfa Aesar’s products can be accessed through the website, along with up-to-date pricing and availability.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

New Cambridge, Office for Alfa Aesar
New and exciting chapter in Alfa Aesar’s UK history.
Tuesday, June 02, 2015
Alfa Aesar Introduces New “GET” Channel Partner Program
An excellent opportunity for new partners to emerge for Alfa Aesar.
Thursday, April 24, 2014
Scientific News
Drug May Prevent Life-Threatening Muscle Loss in Advanced Cancers
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health.
Chemical Design Made Easier
Rice University scientists prepare elusive organocatalysts for drug and fine chemical synthesis.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Giant Molecules Inhibit Ebola Infection
European researchers have designed a "giant" molecule formed by thirteen fullerenes covered by carbohydrates which, by blocking this receptor, are able to inhibit the cell infection by an artificial ebola virus model.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Fighting Pain with Ketamine
Researchers at the Texas A&M Health Science Center are using ketamine, a drug that already exists as an anesthetic, to treat pain.
Possible New Treatment for Neurodegenerative Diseases Found
Researchers at the University of Liverpool have found that a well-established anti-epileptic drug could also be used as a treatment for neurodegenerative diseases.
Breast Cancer Drug Beats Superbug
Tamoxifen helps white blood cells clear multidrug-resistant bacteria in lab and mouse studies.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos